Ratio Therapeutics, Inc. — Form D

Ratio Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-21. The offering totals $50.7M, of which $50.7M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
John W BabichDirectorBoston, MA
Allan W GreenDirectorBoston, MA
Scott W HolbrookDirectorBoston, MA
Albert W HolmanDirectorBoston, MA
John W HoppinDirectorBoston, MA
Susan W WhoriskeyDirectorBoston, MA
John W BabichExecutive OfficerBoston, MA
Matthias W FriebeExecutive OfficerBoston, MA
John W GarveyExecutive OfficerBoston, MA
Jacob W HestermanExecutive OfficerBoston, MA
Shawn W HillierExecutive OfficerBoston, MA
John W HoppinExecutive OfficerBoston, MA
Reed W MalleckExecutive OfficerBoston, MA
Scott MacDonaldRelated PersonBoston, MA
Marc BeckerRelated PersonBoston, MA
Brandon IngersollRelated PersonBoston, MA
Allan GreenRelated PersonBoston, MA
John W. HoppinRelated PersonBoston, MA
John BabichRelated PersonBoston, MA
William CowanRelated PersonBoston, MA
Susan WhoriskeyRelated PersonBoston, MA
Albert HolmanRelated PersonBoston, MA

Other filings by this issuer (1)

FiledFormOfferingSold
2026-07-31D$70.0M$70.0M

More